Pyrosequencing for rapid detection of Tuberculosis resistance in clinical isolates and Sputum samples from re-treatment Pulmonary Tuberculosis patients

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Zheng, Ruijuan ^a   Zhu, Changtai ^b   Guo, Qi ^a   Qin, Lianhua ^a   Wang, Jie ^a   Lu, Junmei ^a   Cui, Haiyan ^a   Cui, Zhenling ^a   Ge, Baoxue ^a   Liu, Jinming ^a   Hu, Zhongyi ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING) A; ETHAMBUTOL; ISONIAZID; KATG PROTEIN; OFLOXACIN; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; DRUG DETERMINATION; EMBB GENE; GYRA GENE; HIGH THROUGHPUT SEQUENCING; HUMAN; INTERMETHOD COMPARISON; KATG GENE; LUNG TUBERCULOSIS; MEASUREMENT ACCURACY; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PYROSEQUENCING; RPOB GENE; RPSL GENE; RRS GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SPUTUM ANALYSIS;

ANTITUBERCULAR AGENTS; DNA, BACTERIAL; GENES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; MUTATION; MYCOBACTERIUM TUBERCULOSIS; SEQUENCE ANALYSIS, DNA; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84899485835     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-200     Document Type: Article

References (34)

1. Prammananan T, Chaiprasert A, Leechawengwongs M. In vitro activity of linezolid against multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant (XDR)-TB isolates. Int J Antimicrob Agents 2009, 33(2):190-191. 10.1016/j.ijantimicag.2008.08.007, 18945598.
2. Pieroni M, Tipparaju SK, Lun S, Song Y, Sturm AW, Bishai WR, Kozikowski AP. Pyrido[1,2-a]benzimidazole-based agents active against tuberculosis (TB), multidrug-resistant (MDR) TB and extensively drug-resistant (XDR) TB. ChemMedChem 2011, 6:334-342. 10.1002/cmdc.201000490, 21259445.
3. Denholm J. The most recent report from the World Health Organization found that, worldwide, approximately 5% of new tuberculosis cases are caused by multidrug-resistant strains (MDR TB). J Travel Med 2010, 17(3):216. 10.1111/j.1708-8305.2009.00396.x, 20536899.
4. World Health Organization Towards universal access to diagnosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis by 2015 2011, Geneva, WHO progress report, World Health Organization.
5. World Health Organization Tuberculosis profile- Bangladesh (high TB burden; high MDR-TB burden). WHO progress report 2010 World Health Organization, World Health Organization.
6. Noeske J, Voelz N, Fon E, Abena Foe JL. Early results of systematic drug susceptibility testing in pulmonary tuberculosis retreatment cases in Cameroon. BMC Res Notes 2012, 5:160. 10.1186/1756-0500-5-160, 3359176, 22436423.
7. Zhang Y, Yew WW. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009, 13:1320-1330.
8. Ramaswamy S. Musser JM:Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 1998, 79:3-29. 10.1054/tuld.1998.0002, 10645439.
9. Viveiros M, Leandro C, Rodrigues L, Almeida J, Bettencourt R, Couto I, Carrilho L, Diogo J, Fonseca A, Lito L, Lopes J, Pacheco T, Pessanha M, Quirim J, Sancho L, Salfinger M, Amaral L. Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis. J Clin Microbiol 2005, 43:4880-4884. 10.1128/JCM.43.9.4880-4884.2005, 1234138, 16145166.
10. Rossau R, Traore H, De Beenhouwer H, Mijs W, Jannes G, De Rijk P, Portaels F. Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother 1997, 41:2093-2098. 164076, 9333031.
11. Sandgren A, Strong M, Muthukrishnan P, Weiner BK, Church GM, Murray MB. Tuberculosis drug resistance mutation database. PLoS Med 2009, 6:e2. 10.1371/journal.pmed.1000002, 2637921, 19209951.
12. Ramasubban G, Therese KL, Vetrivel U, Sivashanmugam M, Rajan P, Sridhar R, Madhavan HN, Meenakshi N. Detection of novel coupled mutations in the katG gene (His276Met, Gln295His and Ser315Thr) in a multidrug-resistant Mycobacterium tuberculosis strain from Chennai, India, and insight into the molecular mechanism of isoniazid resistance using structural bioinformatics approaches. Int J Antimicrob Agents 2011, 37:368-372. 10.1016/j.ijantimicag.2010.11.023, 21330112.
13. Ando H, Kitao T, Miyoshi-Akiyama T, Kato S, Mori T, Kirikae T. Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis. Mol Microbiol 2011, 79:1615-1628. 10.1111/j.1365-2958.2011.07547.x, 21244531.
14. Engstrom A, Perskvist N, Werngren J, Hoffner SE, Jureen P. Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 2011, 66:1247-1254. 10.1093/jac/dkr109, 21427106.
15. Piton J, Petrella S, Delarue M, Andre-Leroux G, Jarlier V, Aubry A, Claudine Mayer-mail C. Structural insights into the quinolone resistance mechanism of Mycobacterium tuberculosis DNA gyrase. PLoS One 2010, 5:e12245. 10.1371/journal.pone.0012245, 2923608, 20805881.
16. Wang F, Shen H, Guan M, Wang Y, Feng Y, Weng X, Wang H, Zhang W. High-resolution melting facilitates mutation screening of rpsL gene associated with streptomycin resistance in Mycobacterium tuberculosis. Microbiol Res 2011, 166:121-128. 10.1016/j.micres.2010.02.001, 20554182.
17. Park KS, Kim JY, Lee JW, Hwang YY, Jeon K, Koh WJ, Ki CS, Lee NY. Comparison of the Xpert MTB/RIF and Cobas TaqMan MTB assays for detection of Mycobacterium tuberculosis in respiratory specimens. J Clin Microbiol 2013, 51(10):3225-3227. 10.1128/JCM.01335-13, 3811628, 23863563.
18. Lyu J, Kim MN, Song JW, Choi CM, Oh YM, Lee SD, Kim WS, Kim DS, Shim TS. GenoType® MTBDRplus assay detection of drug-resistant tuberculosis in routine practice in Korea. Int J Tuberc Lung Dis 2013, 17(1):120-124. 10.5588/ijtld.12.0197, 23232012.
19. Ronaghi M, Uhlen M, Nyren P. A sequencing method based on real-time pyrophosphate. Science 1998, 281:363-365.
20. Nyren P. The history of pyrosequencing. Methods Mol Biol 2007, 373:1-14. 10.1016/j.jmb.2007.07.038, 17185753.
21. Ronaghi M, Karamohamed S, Pettersson B, Uhlen M, Nyren P. Real-time DNA sequencing using detection of pyrophosphate release. Anal Biochem 1996, 242:84-89. 10.1006/abio.1996.0432, 8923969.
22. Jureen P, Engstrand L, Eriksson S, Alderborn A, Krabbe M, Hoffner SE. Rapid detection of rifampin resistance in Mycobacterium tuberculosis by Pyrosequencing technology. J Clin Microbiol 2006, 44:1925-1929. 10.1128/JCM.02210-05, 1489404, 16757581.
23. Garza-Gonzalez E, Gonzalez GM, Renteria A, Cruz-Pulido W, Rivera G, Bocanegra-Garcia V. A pyrosequencing method for molecular monitoring of regions in the inhA, ahpC and rpoB genes of Mycobacterium tuberculosis. Clin Microbiol Infect 2010, 16:607-612. 10.1111/j.1469-0691.2009.02932.x, 19673965.
24. Garcia-Sierra N, Lacoma A, Prat C, Haba L, Maldonado J, Ruiz-Manzano J, Gavin P, Samper S, Ausina V, Dominguez J. Pyrosequencing for rapid molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2011, 49:3683-3686. 10.1128/JCM.01239-11, 3187309, 21813715.
25. Kahla IB, Henry M, Boukadida J, Drancourt M. Pyrosequencing assay for rapid identification of Mycobacterium tuberculosis complex species. BMC Res Notes 2011, 4:42. 10.1186/1756-0500-4-42, 3055820, 21356038.
26. Huq F, Moyen Uddin M. Isolation and identification of mycobacteria from patients with pulmonary tuberculosis. Bangladesh Med Res Counc Bull 1984, 10:39-44.
27. Camus JC, Pryor MJ, Medigue C, Cole ST. Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv. Microbiology 2001, 148:2967-2973.
28. Garrigó M, Aragón LM, Alcaide F, Borrell S, Cardeñosa E, Galán JJ, Gonzalez-Martín J, Martin-Casabona N, Moreno C, Salvado M, Coll P. Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460 TB system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2007, 45(6):1766-1770. 10.1128/JCM.02162-06, 1933104, 17442793.
29. Engstrom A, Morcillo N, Imperiale B, Hoffner SE, Jureen P. Detection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing. J Clin Microbiol 2012, 50:2026-2033. 10.1128/JCM.06664-11, 3372151, 22461677.
30. Kiepiela P, Bishop KS, Smith AN, Roux L, York DF. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Tuber Lung Dis 2000, 80:47-56. 10.1054/tuld.1999.0231, 10897383.
31. Cuevas-Córdoba B, Cuellar-Sánchez A, Pasissi-Crivelli A, Santana-Álvarez CA, Hernández-Illezcas J. Zenteno-Cuevas R:rrs and rpsL mutations in streptomycin-resistant isolates of Mycobacterium tuberculosis from Mexico. J Microbiol Immunol Infect 2013, 46(1):30-34. 10.1016/j.jmii.2012.08.020, 23040237.
32. Seagar AL, Neish B, Laurenson IF. Comparison of two in-house real-time PCR assays with MTB Q-PCR Alert and GenoType MTBDRplus for the rapid detection of mycobacteria in clinical specimens. J Med Microbiol 2012, 61:1459-1464. 10.1099/jmm.0.043166-0, 22790204.
33. Sreevatsan S, Stockbauer KE, Pan X, Kreiswirth BN, Moghazeh SL, Jacobs WR, Telenti A, Musser JM. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother 1997, 41:1677-1681. 163984, 9257740.
34. Ilina EN, Shitikov EA, Ikryannikova LN, Alekseev DG, Kamashev DE, Malakhova MV, Parfenova TV, Afanas'ev MV, Ischenko DS, Bazaleev NA, Smirnova TG, Larionova EE, Chernousova LN, Beletsky AV, Mardanov AV, Ravin NV, Skryabin KG, Vadim MG. Comparative Genomic Analysis of Mycobacterium tuberculosis Drug Resistant Strains from Russia. PLoS One 2013, 8(2):e56577. 10.1371/journal.pone.0056577, 3577857, 23437175.